Why raise awareness – to save lives? Why raise awareness – to reduce disability?

Slides:



Advertisements
Similar presentations
Chapter 30 Early Intervention Overview Rationale for early intervention services Principles of early intervention Services and supports available for early.
Advertisements

Metastatic spinal cord compression
National Collaborating Centre for Acute Care Jacqueline Dutchak, Director 5 December 2001.
Implementing the Dignity Challenge
The Patient Safety Challenge in the UK Dr Kevin Cleary Medical Director National Patient Safety Agency.
Living well with dementia: more timely diagnosis and early intervention Louise Robinson Professor of Primary Care and Ageing RCGP National Clinical Champion.
Understanding Statistics in Research Articles Elizabeth Crabtree, MPH, PhD (c) Director of Evidence-Based Practice, Quality Management Assistant Professor,
Looking for a neurophysiological marker of Autism Spectrum Disorders in Infants and Toddlers Julia M. Stephen, PhD MRN Research Scientist.
Jaime Smith Schools Manager ChildLine Schools Service London and the South East.
Evaluation of the Older Adults Specialist Intervention Service Christina Richards Clinical Services Manager and Head of Therapies.
Cancer practice profiles Just another set of league tables or something useful to help us understand and address differences in results? Phil Bennett-Richards.
Early Diagnosis of Cancer Working with GP Practices in Islington.
Concussion What do parents know? Dr. Kirstin Weerdenburg, MD FRCPC Associate Staff Physician Pediatric Emergency Medicine The Hospital for Sick Children,
Cahalans-Month-of-Madness/
West Midlands Cancer Intelligence Unit NHSBSP Surgical QA Data for the Year of Screening 1 April 2002 to 31 March 2003 Dr Gill Lawrence and Professor Jan.
Henrik Møller, Carolynn Gildea, David Meechan, Greg Rubin, Thomas Round, Peter Vedsted Cancer Epidemiology and Population Health, KCL (HM) Public Health.
National Audit of Intermediate Care National Conference Birmingham, Sept 12 th 2012 Professor Finbarr C. MARTIN Geriatrician Guys and St Thomas’ Hospitals.
Palliative Care in the UK – now-and where are we going? Professor Mari Lloyd-Williams Professor and Director of Academic Palliative and Supportive Care.
Increasing awareness and early diagnosis of cancer An update from Primary Care Jo Preston Service Improvement Facilitator NECN Dr Bill Hall Primary Care.
Dr Neil Douglas GP Clinical Lead Child Health.  In the UK responsible for the largest number of disability adjusted life years lost of any single childhood.
Healthy Communities Collaborative Promoting Earlier Presentation of Cancer Symptoms – Lung Breast and Bowel Tina Davies Senior Project Manager.
Progeria By Brent J. Some information Progeria is associated with a short lifespan. The average patient survives to the early teens. However, some patients.
© Cancer Research UK 2002 Registered charity number Figure One: Numbers of new cases and rates by age and sex, brain and other central nervous.
The case for HIV testing A presentation for the clinical team in your practice.
National Cancer Intelligence Network data usage 17 November 2015 – Veronique Poirier – Principal Cancer Analyst – NCIN.
BRIGHTLIGHT: emerging results Dr Rachel Taylor on behalf of the BRIGHTLIGHT Team.
BRIGHTLIGHT The 2012 TYA cancer cohort Study Professor Jeremy Whelan Professor of Cancer Medicine and Consultant Oncologist Dr Lorna Fern NCRI Teenage.
Anne Snow, Lead Cancer Nurse Dr Andrew Woolley – Consultant Physician.
Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.
EPI 5344: Survival Analysis in Epidemiology Week 6 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine, University of Ottawa 03/2016.
Dr Michelle Webb Renal Consultant, Associate Medical Director Patient Safety, East Kent Hospitals University NHS Foundation Trust and Co-lead for Sepsis.
Malignancies in Young People Sophie Herbert, Alison Barbour, Eva Jungmann, Caroline Foster on behalf of the HIV Young Persons Network (HYPNET)
Parents’ Question Could we have diagnosed this earlier?
Adult Social Care and Health Select Committee Cancer in Nottingham Julie O’Boyle Specialty Registrar Public Health NHS Nottingham City Dr Chris Packham.
Results Introduction There are social inequalities in breast cancer survival with those in more deprived and Black ethnic groups having lower survival.
Please go to & enter the code
Home healthcare – an economic choice for the Health Service?
Behavioural and emotional problems in young children with intellectual disabilities and/or autism: Implications for Early Intervention Richard Hastings.
Greg Rubin,1 Nafees Din,2 Richard Neal,2 William Hamilton3
Age-Standardised Ten-Year Net Survival for the Most Common Cancers in Females, England and Wales, Ten-year survival for is predicted.
Age-Standardised Five-Year Net Survival, England and Wales
Raising Awareness of Bowel Screening in the Workplace
Non-Hodgkin Lymphoma (C82-C85):
Cancer Diagnosis in the Acute Setting (CaDiAS)
All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl
Stomach Cancer (C16): Net Survival up to Ten Years after Diagnosis, Adults (Aged 15-99), England and Wales Please include the citation provided.
Headaches Jo swallow.
Age-Standardised One-Year Net Survival, England and Wales
Bladder Cancer (C67): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-99, England & Wales 1-Year 5-Year 10-Year Survival (%) Survival.
Ovarian Cancer (C56 C57.0-C57.7):
(95% confidence interval)
Kidney Cancer (C64-C66 C68): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-99, England & Wales 1-Year 5-Year 10-Year Survival (%)
Lung Cancer (C33-C34): Age-Standardised Five-Year Net Survival, England and Wales Please include the citation provided in our Frequently Asked.
Dr James Carlton, Medical Adviser
INNOVATIVE, INTERPROFESSIONAL SIMULATION
Humber, Coast and Vale Cancer Alliance
Treatment breakdown for salivary gland cancers
Symptom Management: Terminal Agitation J28 & J29
Symptom Management: Terminal Agitation L21
Brain Cancer (C71): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-99, England & Wales 1-Year 5-Year 10-Year Survival (%) Survival.
National Cancer Diagnosis Audit
Barts Health Trust 2WW Colorectal Workshop Dr Angela Wong,
Intensive Care Syndrome: Promoting Independence and Return to Employment (InS:PIRE) Results and Findings.
(95% confidence interval)
Brain Cancer (C71): Age-Standardised Five-Year Net Survival, England and Wales Please include the citation provided in our Frequently Asked Questions.
Chloe Saunders, Healthcare Project Officer, Macmillan Cancer Support
Clinical Economics Journal of Pain and Symptom Management
Brain Cancer (C71): Net Survival up to Ten Years after Diagnosis, Adults (Aged 15-99), England and Wales Please include the citation provided.
Missed opportunities for diagnosing brain tumours in primary care: a qualitative study of patient experiences by Fiona M Walter, Clarissa Penfold, Alexis.
Presentation transcript:

Why raise awareness – to save lives?

Why raise awareness – to reduce disability?

Acknowledgement Ms Jo Fen Liu Miss Maya Sussman Dr Sophie Wilne Professor Richard Grundy Professor Colin Kennedy Professor Jacqueline Collier Dr William Whitehouse Dr Gabby Chow Professor Michel Coleman Dr Thomas Chu London School of Hygiene and Tropical Medicine All Party Parliamentary Party Group HEADSMART Clinical Champions HEADSMART Project Team Jan Dudley - Chair Julia Trussler Paul Carbury Sarah Lindsell Lucie Clough Dr Peter Lachman Ian Phillips Dr Monica Lakhanpaul Neil and Angela Dickson HEADSMART Community Champions and Volunteers

Sustainability

3 into 1

Public Awareness Professional Awareness Enhance the experience of consultation ++ Reassure Review Refer

Sustainability

Professional Awareness - Confidence How confident are you in your ability to recognise when a child might have a brain tumour? Low? Intermediate? High?

How confident are you in your ability to recognise when a child might have a brain tumour?

Which of the following symptoms and signs do you think may occur in a child with a brain tumour? Symptom : abnormal head position

HeadSmart Clinical Champions

Median Symptom Interval All patients 8.0 weeks (min 0, MAX 398.1) 1.8 months (min 0, MAX 91.6) Pre-launch 9.2 weeks (min 0, MAX 398.1) 2.1 months (min0, MAX 91.6) Post-launch 7.4 weeks (min 0, MAX 363.6)1.7 months (min0, MAX 83.6) Median Symptom Interval All patients 8.0 weeks (min 0, MAX 398.1) 1.8 months (min 0, MAX 91.6) Pre-launch 9.2 weeks (min 0, MAX 398.1) 2.1 months (min0, MAX 91.6) Post-launch 7.4 weeks (min 0, MAX 363.6)1.7 months (min0, MAX 83.6) Symptom Interval by Month of Diagnosis (weeks) Symptom Interval by Month of Diagnosis (weeks) (Jan2011-Jan 2012, data extracted 30/01/2012) P25 – Median – P75  Sample size <10

Significant difference across 3 cohorts (Kruskal-Wallis test, p<0.01) No significant difference between pre- vs post-launch (Mann-Whitney U test, p=0.136) Median Symptom Interval (months) Multi-centre Studies in the UK P25 – Median- P75 30/01/2012

Professional Awareness – Symptom Interval What do you think is the average time from symptom interval currently experienced by children diagnosed with a brain tumour in England? <1 month 1-2 month 2-3 month 3-4 month 5-6 month >6 month

Professional Awareness – Symptom Interval What do you think is the average time from symptom interval currently experienced by children diagnosed with a brain tumour in England?

Delayed Diagnosis of Cancer: Thematic Review NPSA March 2010 / NRLS Groups 1 and 2

National Reporting and Learning System (NRLS)